DexCom Inc (DXCM) support and resistance · P/E 63, rev $2.50B
DexCom Inc (DXCM) is a medical devices company listed on US.
This page maps DexCom Inc (DXCM) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new DXCM 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the DXCM quote page for the session range and the stock page for the full model.
Not investment advice.